Growth Factor

Growth factors, such as VEGF and PDGF, are involved in angiogenesis and vascular remodeling, influencing cardiovascular health and disease progression. Our growth factor inhibitors target these pathways, aiding in research on abnormal vascular growth, plaque stability, and atherosclerosis. These inhibitors are vital for studies on cardiovascular remodeling, neovascularization, and the prevention of pathological angiogenesis in cardiovascular disease. By blocking specific growth factor receptors, researchers can explore therapies that limit harmful blood vessel formation and improve plaque stability, potentially preventing complications like heart attacks and stroke. This range is suited for scientists aiming to understand vascular biology and develop targeted treatments that control growth factor-driven cardiovascular conditions and prevent adverse outcomes in atherosclerosis and related diseases.